Immunome (IMNM) Research & Development (2019 - 2026)
Immunome (IMNM) posted Research & Development of $46.4 million for Q1 2026, down 8.64% on a QoQ basis from $50.8 million in Q4 2025, and up 25.79% year-over-year from $36.9 million in Q1 2025.
Immunome (IMNM) Research & Development (2019 - 2026) Analysis & Trends
Immunome's Research & Development history runs 8 years deep, the most recent figure standing at $46.4 million for Q1 2026.
- Quarterly Research & Development rose 25.79% year-over-year to $46.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $186.8 million (up 23.67% YoY) and the FY2025 annual result came in at $177.3 million, up 36.86% from the prior year.
- Research & Development was $46.4 million for Q1 2026 at Immunome, down from $50.8 million in the prior quarter.
- Across five years, Research & Development topped out at $50.8 million in Q4 2025 and bottomed at $3.8 million in Q3 2023.
- A 5-year average of $23.5 million and a median of $15.4 million in 2024 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2023 — Research & Development plunged 51.56% — and 2024, when it surged 873.06%.
- Immunome's Research & Development stood at $4.3 million in 2022, then soared by 126.65% to $9.6 million in 2023, then jumped by 396.94% to $47.9 million in 2024, then increased by 6.01% to $50.8 million in 2025, then retreated by 8.64% to $46.4 million in 2026.
- Business Quant data shows IMNM's Research & Development at $46.4 million in Q1 2026, $50.8 million in Q4 2025, and $49.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Immunome | 2.51 Bn | 1.93 Bn | - | 46.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.38 Mn |
| Dec 31, 2025 | 50.77 Mn |
| Sep 30, 2025 | 49.19 Mn |
| Jun 30, 2025 | 40.45 Mn |
| Mar 31, 2025 | 36.87 Mn |
| Dec 31, 2024 | 47.89 Mn |
| Sep 30, 2024 | 37.20 Mn |
| Jun 30, 2024 | 29.08 Mn |
| Mar 31, 2024 | 15.37 Mn |
| Dec 31, 2023 | 9.64 Mn |
| Sep 30, 2023 | 3.82 Mn |
| Jun 30, 2023 | 5.72 Mn |
| Mar 31, 2023 | 3.91 Mn |
| Dec 31, 2022 | 4.25 Mn |
| Sep 30, 2022 | 5.23 Mn |
| Jun 30, 2022 | 5.72 Mn |
| Mar 31, 2022 | 8.08 Mn |
| Dec 31, 2021 | 4.39 Mn |
| Sep 30, 2021 | 4.51 Mn |
| Jun 30, 2021 | 3.23 Mn |